glp-1 attorney in louisiana A grand jury indicts Louisiana's general a fight over changes to New Orleans courts glp-1 gastroparesis attorney in kentucky

Cardiorenal outcomes with dapagliflozin by baseline glucose-lowering agents: post hoc analyses from DECLARE-TIMI 58

The outcome no one measured (until recently) The most striking finding from the Batsis review: among 36 primary studies, none reported objective physical function outcomes

Many patients abandon the drug in a matter of months, due to cost, availability, and side effects

[DOI] [PubMed] [Google Scholar] [42].Meng W, Ellsworth BA, Nirschl AA, McCann PJ, Patel M, Girotra RN, Wu G, Sher PM, Morrison EP, Biller SA, Zahler R, Deshpande PP, Pullockaran A, Hagan DL, Morgan N, Taylor JR, Obermeier MT, Humphreys WG, Khanna A, Discenza L, Robertson JG, Wang A, Han S, Wetterau JR, Janovitz EB, Flint OP, Whaley JM, Washburn WN, Journal of Medicinal Chemistry 2008, 51, 1145

Vomiting A similar trend was observed for vomiting for most GLP-1 RAs, except for Exenatide, for which the risk increased linearly and at very high values